- Home
- ECOR vs ONCY Comparison
ECOR vs ONCY Comparison
Compare ECOR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- ONCY
- Stock Information
- Founded
- ECOR 2005
- ONCY 1998
- Country
- ECOR United States
- ONCY Canada
- Employees
- ECOR N/A
- ONCY N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ONCY Pharmaceuticals and Biotechnology
- Sector
- ECOR Health Care
- ONCY Health Care
- Exchange
- ECOR Nasdaq
- ONCY Nasdaq
- Market Cap
- ECOR 50.1M
- ONCY 49.1M
- IPO Year
- ECOR 2018
- ONCY 1999
- Fundamental
- Price
- ECOR $6.11
- ONCY $0.91
- Analyst Decision
- ECOR Strong Buy
- ONCY Strong Buy
- Analyst Count
- ECOR 2
- ONCY 4
- Target Price
- ECOR $25.50
- ONCY $4.33
- AVG Volume (30 Days)
- ECOR 71.2K
- ONCY 1.4M
- Earning Date
- ECOR 08-06-2025
- ONCY 07-31-2025
- Dividend Yield
- ECOR N/A
- ONCY N/A
- EPS Growth
- ECOR N/A
- ONCY N/A
- EPS
- ECOR N/A
- ONCY N/A
- Revenue
- ECOR $26,458,000.00
- ONCY N/A
- Revenue This Year
- ECOR $23.21
- ONCY N/A
- Revenue Next Year
- ECOR $44.10
- ONCY N/A
- P/E Ratio
- ECOR N/A
- ONCY N/A
- Revenue Growth
- ECOR 41.54
- ONCY N/A
- 52 Week Low
- ECOR $4.47
- ONCY $0.33
- 52 Week High
- ECOR $19.49
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- ECOR 62.63
- ONCY 78.49
- Support Level
- ECOR $5.13
- ONCY $0.71
- Resistance Level
- ECOR $5.69
- ONCY $0.81
- Average True Range (ATR)
- ECOR 0.42
- ONCY 0.09
- MACD
- ECOR 0.09
- ONCY 0.02
- Stochastic Oscillator
- ECOR 91.27
- ONCY 90.48
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.